Log in to save to my catalogue

Considering BCG vaccination to reduce the impact of COVID-19

Considering BCG vaccination to reduce the impact of COVID-19

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7252177

Considering BCG vaccination to reduce the impact of COVID-19

About this item

Full title

Considering BCG vaccination to reduce the impact of COVID-19

Publisher

England: Elsevier Ltd

Journal title

The Lancet (British edition), 2020-05, Vol.395 (10236), p.1545-1546

Language

English

Formats

Publication information

Publisher

England: Elsevier Ltd

More information

Scope and Contents

Contents

In addition to its specific effect against tuberculosis, the BCG vaccine has beneficial nonspecific (off-target) effects on the immune system that protect against a wide range of other infections and are used routinely to treat bladder cancer.1,2 This has led to the suggestion that vaccination with BCG might have a role in protecting health-care wo...

Alternative Titles

Full title

Considering BCG vaccination to reduce the impact of COVID-19

Authors, Artists and Contributors

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7252177

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7252177

Other Identifiers

ISSN

0140-6736

E-ISSN

1474-547X

DOI

10.1016/S0140-6736(20)31025-4

How to access this item